Leonard T B, Lyght O, Popp J A
Carcinogenesis. 1983 Aug;4(8):1059-61. doi: 10.1093/carcin/4.8.1059.
Technical grade dinitrotoluene (TDNT), composed principally of 2,4-DNT (76%) and 2,6-DNT (20%), is a potent hepatocarcinogen when fed to male F-344 rats for 1 year (100% incidence of hepatocellular carcinoma) while 2,4-DNT is only weakly hepatocarcinogenic. The present investigation was designed to determine the relative initiating potential of DNT isomers compared with the initiating potential of TDNT. A single administration of either TDNT or 2,6-dinitrotoluene (75 mg/kg, p.o.), in combination with partial hepatectomy, initiated hepatocytes in rats when assayed using hepatic initiation-promotion protocols. Five other DNT isomers (2,3; 2,4; 2,5; 3,4, and 3,5-DNT) evaluated similarly exhibited no such potential. Although 2,6-DNT was a relatively weak initiator, its activity was comparable to the initiating activity detected in TDNT. These data begin to provide an explanation for the marked differences in the hepatocarcinogenic potency of TDNT and 2,4-DNT observed in independent 2 year bioassays.
工业级二硝基甲苯(TDNT)主要由2,4 - 二硝基甲苯(76%)和2,6 - 二硝基甲苯(20%)组成,当给雄性F - 344大鼠喂食1年时,它是一种强效的肝癌致癌物(肝细胞癌发生率为100%),而2,4 - 二硝基甲苯的肝癌致癌性较弱。本研究旨在确定二硝基甲苯异构体与TDNT的引发潜力相比的相对引发潜力。当使用肝脏启动 - 促进方案进行检测时,单次口服给予TDNT或2,6 - 二硝基甲苯(75毫克/千克)并结合部分肝切除术,可引发大鼠肝细胞癌变。以类似方式评估的其他五种二硝基甲苯异构体(2,3;2,4;2,5;3,4和3,5 - 二硝基甲苯)未表现出这种潜力。虽然2,6 - 二硝基甲苯是一种相对较弱的引发剂,但其活性与在TDNT中检测到的引发活性相当。这些数据开始为在独立的两年生物测定中观察到的TDNT和2,4 - 二硝基甲苯肝癌致癌效力的显著差异提供了解释。